Zydus Lifesciences Ltd gets 3 observations from USFDA for Pharmex, Ahmedabad facility

The company has announced that the USFDA conducted an inspection at the manufacturing facility SEZ-1 of Zydus Lifesciences Limited located at Pharmez, Ahmedabad from March 20 to 24, 2023.

The inspection was a Pre-Approval Inspection (PAI) as well as a GMP Audit and concluded with three observations. There were no Data Integrity related observations.

The Company is addressing these observations and will respond to them within the stipulated time.

Shares of Cadila Healthcare Limited was last trading in BSE at Rs. 480.50 as compared to the previous close of Rs. 482.35. The total number of shares traded during the day was 53217 in over 2598 trades.

The stock hit an intraday high of Rs. 487.00 and intraday low of 478.65. The net turnover during the day was Rs. 25702713.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 USFDA GMPAudit PreApprovalInspection 3Observations Pharmez Ahmedabad